Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Glaucoma drug methazolamide shows potential in fighting neurodegenerative diseases, offering new hope for treating conditions ...

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...

A 65-year-old retired nurse said she had got her life back thanks to a new drug used to treat Parkinson's disease which controls tremors. Jan Fuller, who lives in Hopton-on-Sea near Great Yarmouth ...

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that ...

Opens in a new tab or window Share on X ... The overall findings "suggest that perhaps we need to investigate this pathway, ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...